| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.5 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |